Evaluation of Enfuvirtide-loaded Nanoparticles for Oral Administration - New Treatment Option for HIV/AIDS (2021–2023)

Grant type:
Australian Centre for HIV and Hepatitis Virology Research (ACH2)
Researchers:
  • Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Australian Centre for HIV and Hepatitis Virology Research (ACH2)